BioStructures' Signafuse bone graft putty reaches 4k implantation milestone: 3 facts

Spinal Tech

BioStructures' Signafuse Bioactive Bone Graft Putty has been used in 4,000 implantations.

Here are three facts:

 

1. Signafuse received FDA 510(k) clearance in 2014 as bone void filler for standalone use in posterolateral spine fusion procedures.  

 

2. Signafuse is a moldable bone graft comprised of patented bioactive glass particles and biphasic mineral granules suspended in a patented resorbable polymer carrier.

 

3. BioStructures is a medical device company focused on developing proprietary platforms in bioresorbable bone graft products for a range of spinal and orthopedic fusion procedures.  

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers